Akhiok-Kaguyak, Inc. bringing Smart Biometric Technology to the Federal Marketplace
Akhiok-Kaguyak, Inc. (AKI), an Alaska Native Corporation, announced today an exclusive partnership with autonomous_ID, makers of integrated biometric consumer technology. AKI will market the Ottawa-based Canadian firm’s proprietary BIO_SOLE product to U.S. federal customers. BIO_SOLE is a self-contained biometric credentialing system designed to meet the security and mobility needs of identity and access control automation.
The two tech companies expressed shared enthusiasm about the strategic partnership. “BIO_SOLE is the ultimate in actionable information when you think of data analytics, the modern warrior and predictive operational performance. Not only do we know location, we can observe individual bio-stats in real time, providing enhanced situational awareness to allow for corrective actions,” says AKI CEO Michael Bradshaw. “BIO_SOLE is suitable for the most sensitive controlled-access applications. Its reliable and consistent performance eliminates security risks associated with lost swipe cards, compromised access codes and identity theft. We have seen tremendous advances in biometrics in a short time, and they will continue to evolve to a point we won’t even know they are there.”
“The continuing threats to military personnel and critical infrastructure and the growing national cybersecurity vulnerabilities demand a new breed of credentialing technology, and what our group has achieved is pivotal,” says autonomous_ID President Todd Gray. “Our product can identify a person within three steps with more than 99 percent accuracy. If I put on yours, it would know almost instantly that I’m not you.”
BIO_SOLE is the ultimate in actionable information when you think of data analytics, the modern warrior and predictive operational performance.
BIO_SOLE has applicability as a security tool and also potential medical uses, such as identifying the onset of diseases like diabetes and Parkinson’s. BIO_SOLE can characterize the identity of individuals, analyze sports performance, assess characteristics of health markers, assess and track progress in medical responses to diseases that manifest their presence and pathologies in the foot, and measure walking and running gaits as biomarkers for disease pathologies.